Skip Navigation


JAC Advance Access originally published online on October 16, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
52/5/856    most recent
dkg452v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Shultz, T. R.
Right arrow Articles by Richardson, C. J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shultz, T. R.
Right arrow Articles by Richardson, C. J. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Journal of Antimicrobial Chemotherapy (2003) 52, 856-859
© 2003 The British Society for Antimicrobial Chemotherapy

Chloramphenicol-resistant Neisseria meningitidis containing catP isolated in Australia

Tiffany R. Shultz1, John W. Tapsall1,*, Peter A. White2, Catherine S. Ryan3, Dena Lyras3, Julian I. Rood3, Enzo Binotto4 and Christopher J. L. Richardson5

1 Department of Microbiology, South Eastern Sydney Area Health Services, The Prince of Wales Hospital, Sydney 2031; 2 School of Biotechnology and Biomolecular Sciences, Faculty of Science, University of New South Wales, Sydney 2052; 3 Bacterial Pathogenesis Research Group, Department of Microbiology, Monash University 3800; 4 Department of Microbiology and Infectious Diseases, South West Area Pathology Service, Locked Bag 7090 Liverpool BC 1871, Australia; 5 Department of Microbiology, Women’s & Children’s Health Services (WA); Princess Margaret Hospital, GPO Box D184, Perth, Western Australia 6001

Received 9 June 2003; returned 9 July 2003; revised 19 August 2003; accepted 22 August 2003

Earlier workers have described chloramphenicol resistance in meningococci isolated from cerebrospinal fluid sampled in patients in Vietnam (11 cases) and France (one case) during 1987–1996. Here we describe two distinct serogroup B strains isolated in Australia in 1994 and 1997, and found among ~1400 invasive meningococcal isolates examined in Australia over a 9 year period. Both were phenotypically chloramphenicol resistant on disc, Etest and agar inclusion MIC and acetylated chloramphenicol examination. DNA amplification and sequencing confirmed the presence of catP and the 3' end of tnpV from Tn4451, a mobilizable element from Clostridium perfringens, although other sequences were not present. Tn4451 has inserted into a gene designated TIGR locus NMB1350 in both isolates with no loss of DNA and no apparent interruption of virulence genes. This second report of chloramphenicol-resistant meningococci is in a setting with a very low volume of systemic chloramphenicol use, but where the high topical use may contribute to recombination events in vivo. Methods for screening for chloramphenicol resistance in meningococci and the in vitro parameters that define this resistance are ill defined.

Keywords: N. meningitidis, chloramphenicol resistance, antibiotic use, chloramphenicol acetyltransferase, transposons

* Corresponding author. Tel: +612-9382-9079; Fax: +612-9389-9098; E-mail: j.tapsall{at}unsw.edu.au


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Bacteriol.Home page
D. Lyras, V. Adams, S. A. Ballard, W. L. Teng, P. M. Howarth, P. K. Crellin, T. L. Bannam, J. G. Songer, and J. I. Rood
tISCpe8, an IS1595-Family Lincomycin Resistance Element Located on a Conjugative Plasmid in Clostridium perfringens
J. Bacteriol., October 15, 2009; 191(20): 6345 - 6351.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
R. B. Neil and M. A. Apicella
Role of HrpA in Biofilm Formation of Neisseria meningitidis and Regulation of the hrpBAS Transcripts
Infect. Immun., June 1, 2009; 77(6): 2285 - 2293.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. T. Hedberg, H. Fredlund, P. Nicolas, D. A. Caugant, P. Olcen, and M. Unemo
Antibiotic Susceptibility and Characteristics of Neisseria meningitidis Isolates from the African Meningitis Belt, 2000 to 2006: Phenotypic and Genotypic Perspectives
Antimicrob. Agents Chemother., April 1, 2009; 53(4): 1561 - 1566.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
M.-K. Taha, M. L. Zarantonelli, A. Neri, R. Enriquez, J. A. Vazquez, and P. Stefanelli
Interlaboratory Comparison of PCR-Based Methods for Detection of Penicillin G Susceptibility in Neisseria meningitidis
Antimicrob. Agents Chemother., March 1, 2006; 50(3): 887 - 892.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
G. Norheim, E. Rosenqvist, A. Aseffa, M. A. Yassin, G. Mengistu, A. Kassu, D. Fikremariam, W. Tamire, E. A. Hoiby, T. Alebel, et al.
Characterization of Neisseria meningitidis Isolates from Recent Outbreaks in Ethiopia and Comparison with Those Recovered during the Epidemic of 1988 to 1989
J. Clin. Microbiol., March 1, 2006; 44(3): 861 - 871.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
J. H. Jorgensen, S. A. Crawford, and K. R. Fiebelkorn
Susceptibility of Neisseria meningitidis to 16 Antimicrobial Agents and Characterization of Resistance Mechanisms Affecting Some Agents
J. Clin. Microbiol., July 1, 2005; 43(7): 3162 - 3171.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.